nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alcohol intake and late-stage promotion of breast cancer
|
Stoll, B.A |
|
1999 |
35 |
12 |
p. 1653-1658 6 p. |
artikel |
2 |
Bone mineral density in children with acute lymphoblastic leukaemia
|
Boot, A.M. |
|
1999 |
35 |
12 |
p. 1693-1697 5 p. |
artikel |
3 |
Caring about women and cancer (CAWAC)
|
Veronesi, U. |
|
1999 |
35 |
12 |
p. 1667-1675 9 p. |
artikel |
4 |
Comments on: Tagging sentinel lymph nodes: a study of 100 patients with breast cancer. Bobin, et al.., Eur J Cancer 1999, 35, 569–573
|
Sakorafas, G.H |
|
1999 |
35 |
12 |
p. 1743- 1 p. |
artikel |
5 |
Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status
|
Lissoni, P |
|
1999 |
35 |
12 |
p. 1688-1692 5 p. |
artikel |
6 |
Descriptive epidemiology of soft tissue sarcomas in Vaud, Switzerland
|
Levi, F. |
|
1999 |
35 |
12 |
p. 1711-1716 6 p. |
artikel |
7 |
Differential prognosis of replication error phenotype and loss of heterozygosity in sporadic colorectal cancer
|
Massa, M.-J. |
|
1999 |
35 |
12 |
p. 1676-1682 7 p. |
artikel |
8 |
Epidemiological aspects of soft tissue sarcomas (STS)—consequences for the design of clinical STS trials
|
Nijhuis, P.H.A. |
|
1999 |
35 |
12 |
p. 1705-1710 6 p. |
artikel |
9 |
Local therapy and other factors influencing site of relapse in patients with localised Ewing's sarcoma
|
Shankar, A.G. |
|
1999 |
35 |
12 |
p. 1698-1704 7 p. |
artikel |
10 |
Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: identification of three independent regions
|
Lin, Y.-W. |
|
1999 |
35 |
12 |
p. 1730-1734 5 p. |
artikel |
11 |
Mutations in hMSH6 alone are not sufficient to cause the microsatellite instability in colorectal cancer cell lines
|
Ku, J.-L |
|
1999 |
35 |
12 |
p. 1724-1729 6 p. |
artikel |
12 |
Selection of markers to predict tumour response or survival: description of a novel approach
|
McLeod, H.L |
|
1999 |
35 |
12 |
p. 1650-1652 3 p. |
artikel |
13 |
Selective oestrogen receptor modulation
|
Levenson, A.S. |
|
1999 |
35 |
12 |
p. 1628-1639 12 p. |
artikel |
14 |
Should chemotherapy be used as a treatment of advanced colorectal carcinoma (ACC) in patients over 70 years of age?
|
Daniele, B. |
|
1999 |
35 |
12 |
p. 1640-1643 4 p. |
artikel |
15 |
Should chemotherapy be used as a treatment of advanced colorectal carcinoma (ACC) in patients over 70 years of age?
|
Simmonds, P.D |
|
1999 |
35 |
12 |
p. 1643-1647 5 p. |
artikel |
16 |
Should chemotherapy be used as a treatment of advanced colorectal carcinoma (ACC) in patients over 70 years of age?
|
Ross, P.J. |
|
1999 |
35 |
12 |
p. 1647-1649 3 p. |
artikel |
17 |
Suppressive subtractive hybridisation reveals differential expression of serglycin, sorcin, bone marrow proteoglycan and prostate-tumour-inducing gene I (PTI-1) in drug-resistant and sensitive tumour cell lines of haematopoetic origin
|
Beyer-Sehlmeyer, G. |
|
1999 |
35 |
12 |
p. 1735-1742 8 p. |
artikel |
18 |
Tamoxifen added to adjuvant chemotherapy in premenopausal women with early breast cancer: is it standard practice or still a subject for study?
|
Bramwell, V.H.C. |
|
1999 |
35 |
12 |
p. 1625-1627 3 p. |
artikel |
19 |
Tamoxifen in high-risk premenopausal women with primary breast cancer receiving adjuvant chemotherapy. Report from the Danish Breast Cancer Co-operative Group DBCG 82B trial
|
Andersson, M. |
|
1999 |
35 |
12 |
p. 1659-1666 8 p. |
artikel |
20 |
TP53 gene mutation status in pretreatment biopsies of oesophageal adenocarcinoma has no prognostic value
|
Soontrapornchai, P. |
|
1999 |
35 |
12 |
p. 1683-1687 5 p. |
artikel |
21 |
Vitamin D analogues suppress IGF-I signalling and promote apoptosis in breast cancer cells
|
Xie, S.P |
|
1999 |
35 |
12 |
p. 1717-1723 7 p. |
artikel |